Where are we?.

Slides:



Advertisements
Similar presentations
Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
Advertisements

X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx Let X = decrease (–) in cholesterol.
Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.
Class 14 Testing Hypotheses about Means Paired samples 10.3 p
Introduction to Survival Analysis October 19, 2004 Brian F. Gage, MD, MSc with thanks to Bing Ho, MD, MPH Division of General Medical Sciences.
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Lecture 3 Survival analysis. Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival.
Biostatistics in Research Practice Time to event data Martin Bland Professor of Health Statistics University of York
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Survival analysis. First example of the day Small cell lungcanser Meadian survival time: 8-10 months 2-year survival is 10% New treatment showed median.
Analysis of Complex Survey Data
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 10: Survival Curves Marshall University Genomics Core.
Overall agenda Part 1 and 2  Part 1: Basic statistical concepts and descriptive statistics summarizing and visualising data describing data -measures.
Statistics for clinical research An introductory course.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
1 Survival Analysis Biomedical Applications Halifax SAS User Group April 29/2011.
HSRP 734: Advanced Statistical Methods July 10, 2008.
Dr Laura Bonnett Department of Biostatistics. UNDERSTANDING SURVIVAL ANALYSIS.
Lecture 3 Survival analysis.
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
Design and Analysis of Clinical Study 11. Analysis of Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
SIMPLE TWO GROUP TESTS Prof Peter T Donnan Prof Peter T Donnan.
X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx  Let X =  cholesterol level (mg/dL);
Repeated measures ANOVA in SPSS Cross tabulations Survival analysis.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
1 Always be mindful of the kindness and not the faults of others.
01/20151 EPI 5344: Survival Analysis in Epidemiology Survival curve comparison (non-regression methods) March 3, 2015 Dr. N. Birkett, School of Epidemiology,
Statistical Inference for more than two groups Peter T. Donnan Professor of Epidemiology and Biostatistics Statistics for Health Research.
Essential Statistics Chapter 161 Review Part III_A_Chi Z-procedure Vs t-procedure.
Introduction Sample Size Calculation for Comparing Strategies in Two-Stage Randomizations with Censored Data Zhiguo Li and Susan Murphy Institute for Social.
Survival Analysis approach in evaluating the efficacy of ARV treatment in HIV patients at the Dr GM Hospital in Tshwane, GP of S. Africa Marcus Motshwane.
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
Non-parametric Tests e.g., Chi-Square. When to use various statistics n Parametric n Interval or ratio data n Name parametric tests we covered Tuesday.
We’ll now look at the relationship between a survival variable Y and an explanatory variable X; e.g., Y could be remission time in a leukemia study and.
1 Always be mindful of the kindness and not the faults of others.
X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx  Let X = decrease (–) in cholesterol.
Some survival basics Developments from the Kaplan-Meier method October
Section 6.4 Inferences for Variances. Chi-square probability densities.
SURVIVAL ANALYSIS PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Carolinas Medical Center, Charlotte, NC Website:
ANOVA: Analysis of Variation
March 28 Analyses of binary outcomes 2 x 2 tables
Comparison of Two Survival Curves
April 18 Intro to survival analysis Le 11.1 – 11.2
ANOVA: Analysis of Variation
Survival Analysis Rick Chappell, Ph.D. Professor,
The binomial applied: absolute and relative risks, chi-square
Statistical Inference for more than two groups
Statistics 103 Monday, July 10, 2017.
Saturday, August 06, 2016 Farrokh Alemi, PhD.
Statistical Process Control
Defining Resistance and Tolerance to Cancer
Inferential Stat Week 13.
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Heart failure.
Chapter 13 Group Differences
Mintu P. Turakhia et al. JACEP 2016;2:
Categorical Data Analysis
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Chapter 4 SURVIVAL AND LIFE TABLES
Inference for Two Way Tables
Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed  D.
MiR-520d-3p is an independent positive prognostic factor in ovarian cancer. miR-520d-3p is an independent positive prognostic factor in ovarian cancer.
Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.
Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier plots. Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier.
Kaplan-Meier survival curves and the log rank test
Cumulative probability of CIN2 stratified by HPV test results.
Presentation transcript:

Where are we?

Survival analysis

Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: ANOVA on mean survival time? ANOVA on median survival time?

Progressively censored observations Current life table Completed dataset Cohort life table Analysis “on the fly”

First example of the day

Person-year of observation In total: 15.122 days ~ 41.4y 11 patients died: 11/41.4y = 0.266 y-1 26.6 death/100y 1000 patients in 1 y or 100 patients in 10y

Mortality rates 11 of 25 patients died 11/25 = 44% When is the analysis done?

1-year survival rate 6 patients dies the first year 25 patients started 24%

1-year survival rate 3 patients less than 1 year 6/(25-3) = 27% 24% -27%

Actuarial / life table anelysis Treatment for lung cancer

Actuarial / life table anelysis A sub-set of 13 patients undergoing the same treatment

Actuarial / life table anelysis Time interval chosen to be 3 months ni number of patients starting a given period

Actuarial / life table anelysis di number of terminal events, in this example; progression/response wi number of patients that have not yet been in the study long enough to finish this period

Actuarial / life table anelysis Number exposed to risk: ni – wi/2 Assuming that patients withdraw in the middle of the period on average.

Actuarial / life table anelysis qi = di/(ni – wi/2) Proportion of patients terminating in the period

Actuarial / life table anelysis pi = 1 - qi Proportion of patients surviving

Actuarial / life table anelysis Si = pi pi-1 ...pi-N Cumulative proportion of surviving Conditional probability

Survival curves How long will a lung cancer patient keep having cancer on this particular treatment?

Kaplan-Meier Simple example with only 2 ”terminal-events”.

Confidence interval of the Kaplan-Meier method Fx at first terminal event

Confidence interval of the Kaplan-Meier method Survival plot for all data on treatment 1 Are there differences between the treatments?

Comparing Two Survival Curves One could use the confidence intervals… But what if the confidence intervals are not overlapping only at some points? Logrank-stats Hazard ratio Mantel-Haenszel methods

Comparing Two Survival Curves The logrank statistics Aka Mantel-logrank statistics Aka Cox-Mantel-logrank statistics

Comparing Two Survival Curves Divide the data into intervals (eg. 10 months) Count the number of patients at risk in the groups and in total Count the number of terminal events in the groups and in total Calculate the expected numbers of terminal events e.g. (31-40) 44 in grp1 and 46 in grp2, 4 terminal events. expected terminal events 4x(44/90) and 4x(46/90) Calculate the total

Comparing Two Survival Curves Smells like Chi-Square statistics

Comparing Two Survival Curves Hazard ratio

Comparing Two Survival Curves Mantel Haenszel test Is the OR significant different from 1? Look at cell (1,1) Estimated value, E(ai) Variance, V(ai) row total * column total grand total

Comparing Two Survival Curves Mantel Haenszel test df = 1; p>0.05

Hazard function d is the number of terminal events f is the sum of failure times c is the sum of censured times